As a result, we speculate that LPAR5 might enhance phagocytosis and antigen presentation of macrophages, recruiting more CD8+ T cells and CD4+ activated memory T cells to infiltrate the tumor microenvironment and inhibiting tumor cell growth. The gene discussed is CD8A; the disease is neoplasm.